National HealthCare Co. (NYSE:NHC) Shares Sold by Amalgamated Bank

Amalgamated Bank reduced its stake in National HealthCare Co. (NYSE:NHC) by 12.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,590 shares of the company’s stock after selling 507 shares during the quarter. Amalgamated Bank’s holdings in National HealthCare were worth $452,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of NHC. GAMMA Investing LLC grew its holdings in shares of National HealthCare by 35.5% in the third quarter. GAMMA Investing LLC now owns 313 shares of the company’s stock valued at $39,000 after purchasing an additional 82 shares during the period. Evergreen Capital Management LLC grew its stake in shares of National HealthCare by 2.9% in the 2nd quarter. Evergreen Capital Management LLC now owns 3,426 shares of the company’s stock valued at $373,000 after buying an additional 97 shares during the period. Louisiana State Employees Retirement System increased its holdings in shares of National HealthCare by 1.5% during the 2nd quarter. Louisiana State Employees Retirement System now owns 6,800 shares of the company’s stock worth $737,000 after buying an additional 100 shares during the last quarter. Bank of Montreal Can raised its position in shares of National HealthCare by 2.6% during the 2nd quarter. Bank of Montreal Can now owns 3,903 shares of the company’s stock valued at $423,000 after buying an additional 100 shares during the period. Finally, WINTON GROUP Ltd lifted its holdings in National HealthCare by 1.1% in the second quarter. WINTON GROUP Ltd now owns 9,719 shares of the company’s stock valued at $1,054,000 after acquiring an additional 107 shares during the last quarter. 56.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised National HealthCare from a “buy” rating to a “strong-buy” rating in a research note on Saturday.

National HealthCare Trading Down 1.0 %

Shares of NHC opened at $125.86 on Friday. The firm has a 50-day moving average of $123.50. National HealthCare Co. has a 12-month low of $73.96 and a 12-month high of $138.49. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.77 and a current ratio of 1.80. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of 15.77 and a beta of 0.41.

National HealthCare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Monday, December 30th will be paid a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date is Monday, December 30th. National HealthCare’s dividend payout ratio (DPR) is 30.58%.

Insider Transactions at National HealthCare

In related news, SVP Brian F. Kidd sold 2,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.01, for a total value of $260,020.00. Following the sale, the senior vice president now owns 21,747 shares in the company, valued at approximately $2,827,327.47. The trade was a 8.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 13.75% of the company’s stock.

National HealthCare Profile

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.